GlobeImmune raises $17.25 million in IPO
Last Updated: 17:52 July 8, 2014
The Louisville-based biopharmaceutical company sold 1.725 million shares of its common stock for $10 each, including 225,000 shares sold pursuant to the exercise of the underwriter's overallotment option.
The gross proceeds amount is prior to the deduction of underwriting discounts and commissions and other offering expenses.
GlobeImmune shares began trading July 2. The share price closed at $12.89 Tuesday, up 12 percent from the previous day's close.
More breaking news...
Nominees sought for Lafayette's green business awards
The events give community members a chance to learn about the benefits of electric vehicles and even test
Ball Aerospace breaks ground for new clean room
The program, set up by the city’s Energy Sustainability
Investor group buys Mountain Aviation Inc.
Terms of the deal were not disclosed.
Mountain Aviation, based